USPTO serial 77523034
BIOLOGICAL PROSPECTS
Reviewed by CopyMark Law Group
Reg. 3822479Status 710
- Filing date
- Status date
- Registration date
- Jul 20, 2010
- Examiner
- BIBBINS, ODESSA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with BIOLOGICAL PROSPECTS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Analgesic and muscle relaxant pharmaceutical preparations; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Antibacterial pharmaceuticals; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Antimicrobial preservatives for cosmetics and pharmaceuticals; Astringents; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Dietary and nutritional supplements; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary supplemental drinks; Dietary supplements; Dietary supplements for animals; Dietary supplements for human consumption; Dietary supplements for pets; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for tablets, caplets, capsules, pellets, particles, oral dosage forms, dressings, bandages, dermal systems that facilitate the delivery of a wide range of pharmaceuticals; Feed supplements for horses, livestock, dogs, cats, pets and companion animals; Food supplements; Food supplements, namely, anti-oxidants; Herbal anti-itch and sore skin ointment for pets; Herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; Herbal supplements; Herbal teas for medicinal purposes; Herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain; Homeopathic pharmaceuticals for use in the treatment of systemic and topical skin conditions; Homeopathic supplements; Liquid nutritional supplement; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Natural herbal supplements; Non-medicated additives for animal feed for use as nutritional supplements; Nutraceuticals for use as a dietary supplement; Nutritional additives for livestock feed for medical purposes; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Nutritional additives to foodstuffs for animals, for medical purposes; Nutritional drink mix for use as a meal replacement; Nutritional drinks for animals; Nutritional energy bars for use as a meal substitute; Nutritional oils not for cosmetic purposes; Nutritional oils not for food or cosmetic purposes; Nutritional shakes for use as a meal substitute; Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Nutritional supplements; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Nutritive substances for micro-organisms for medical use; Nutritive substances for microorganism cultures; Nutritive substances for microorganisms for medical purposes; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skin care; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti- infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical skin lotions; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, lipid lowering agents; Plant extracts for medical, veterinary and pharmaceutical purposes; Powdered fruit-flavored dietary supplement drink mix; Powdered nutritional supplement drink mix; Protein supplements; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Vitamin and mineral supplements; Vitamin enriched water; Vitamin fortified beverages; Vitamin preparations; Vitamin supplements; Vitamins; Vitamins and dietary food supplements for animals; Vitamins and vitamin preparations; Vitamins for pets | SECTION 8 - CANCELLED | Dec 1, 2008 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 24, 2017 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 20, 2015 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 20, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 16, 2010 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jun 15, 2010 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Jun 15, 2010 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 20, 2010 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 18, 2010 | IUAF | USE AMENDMENT FILED | — |
| May 18, 2010 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 8, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 7, 2010 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 6, 2010 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| May 6, 2010 | PETG | PETITION TO REVIVE-GRANTED | — |
| May 6, 2010 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Apr 5, 2010 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 5, 2010 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 3, 2010 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 1, 2009 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 1, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 4, 2009 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Nov 4, 2009 | PETG | PETITION TO REVIVE-GRANTED | — |
| Nov 4, 2009 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Oct 5, 2009 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 5, 2009 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 3, 2009 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 3, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 9, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 19, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 1, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 1, 2008 | ALIE | ASSIGNED TO LIE | — |
| Oct 23, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 23, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 23, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 23, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 23, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 21, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 21, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 21, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 21, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 19, 2008 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Jul 18, 2008 | NWAP | NEW APPLICATION ENTERED | — |